Abstract Body

There is evidence for endothelial dysfunction in youth living with perinatally acquired HIV (YLPHIV). We assessed gut and inflammatory biomarkers associated with endothelial dysfunction in South African YLPHIV. 

YLPHIV and age-matched HIV-uninfected (HIV-) youth enrolled in the Cape Town Adolescent Antiretroviral Cohort (CTAAC) in South Africa between 9-14 years of age were included.  YLPHIV were on ART> 6 months with viral load <400 copies/mL. Endothelial function was measured using reactive hyperemic index (RHI) by Peripheral Arterial Tonometry. Endothelial dysfunction was defined as RHI <1.35. Serum levels of systemic inflammation, monocyte activation, intestinal integrity and oxidized lipids were measured at baseline and 24 months. RHI was measured at 24 months. Spearman correlations were used and quantile regression models assessed associations with RHI.

We included 283 YLPHIV and 69 HIV- participants.  At baseline, median (Q1, Q3) age was 12 years (11, 13), 53% were females.  There was no difference in age, sex or Tanner stages between the groups.  At baseline, median CD4 cell count was 744 cells/µL (603, 951).  PHIVs had poorer endothelial function compared to HIV- (RHI=1.36 vs 1.52, p<0.01). At baseline and 24 months, YLPHIV had lower BMI but higher waist-to-hip ratio, LDL cholesterol, triglycerides, markers of monocyte activation (sCD14), gut barrier dysfunction (intestinal fatty acid binding protein, IFAB-P) and oxidized LDL cholesterol (p≤0.04).  Several biomarkers decreased at 24 months in YLPHIV but remained elevated compared to HIV- (Figure).  In univariate analyses, higher levels of IFAB-P at baseline and sCD14 at 24 months correlated with endothelial dysfunction at 24 months (p≤0.04).  In quantile regression analyses, in YLPHIV with endothelial dysfunction, sCD14 remained associated with lower RHI after adjusting for age, sex, Tanner stage, viral load and ART duration (β-0.05, p=0.01).  

Despite viral suppression, South African YLPHIV have poor endothelial function and persistent evidence of monocyte activation and gut barrier dysfunction compared to uninfected youth. A key finding in our results is that higher sCD14 is independently associated with endothelial dysfunction in this population.  The long-term clinical significance of gut integrity and monocyte activation needs to be further assessed in YLPHIV.